Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT07111559
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT07111559
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Recruiting
Technical summary
Registry record NCT07111559. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2028-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial
- Acronym
- LACUNAR-tPA
- Condition
- Lacunar Stroke
- Condition
- Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- rt-PA
- Intervention (Drug)
- DAPT
- Lead sponsor
- Nippon Medical School
- Collaborator
- Japan Research Foundation for Clinical Pharmacology
- Collaborator
- Takeda Science Foundation - Medical Research Grant
Record details
- Record id
cardio:ct-nct07111559- Content hash
ecbba76576a455ac0a5499bef083b4006ee5065147f598d14b824a73f44e741a